Lundbeck's partner Teva Pharmaceutical Industries Ltd. has announced that results of the phase III ADAGIO trial were presented during the 12th Congress of European Federation of Neurological Societi
read more » Discuss Add this link to...Bury Add to:
| Bookmarks